J Ruys, J J De Laey, Y Vanderhaeghen, E H Van Aken. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Angiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedBevacizumabChoroidal Neovascularization/drug therapyFemaleHumansMaleMiddle AgedRetinal Diseases/drug therapyTelangiectasis/drug therapy
Substances: See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedBevacizumab
Year: 2007 PMID: 17693997 DOI: 10.1038/sj.eye.6702946
Source DB: PubMed Journal: Eye (Lond) ISSN: 0950-222X Impact factor: 3.775